February 2011 Volume 4 Issue 2
Now available in pdf format for saving and printing and Web page format for viewing online
PDF Format for Saving and Printing
Clinical Thyroidology for Patients February 2011 Volume 4 Issue 2 (PDF file, 798 KB)
TABLE OF CONTENTS – Web Format
THYROID CANCER Management of patients with papillary thyroid microcarcinoma
Durante et al. Identification and optimal postsurgical follow-up of patients with very low-risk papillary thyroid microcarcinomas. J Clin Endocrinol 2010;95:4882-8
(PDF File for saving and printing, 93 KB)
THYROID CANCER Medullary Thyroid Carcinoma: prevalence and the case for screening
Article 1: Valle LA, Kloos RT. The prevalence of occult medullary thyroid carcinoma at autopsy. J Clin Endocrinol Metab. October 13, 2010. doi:10.1210/jc.2010-0959
Article 2: Chambon G et al. The use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disorders: results from 2733 consecutive patients. J Clin Endocrinol Metab. September 29, 2010. doi:10.1210/jc.2010-0162.
(PDF File for saving and printing, 123 KB)
THYROID NODULES Shear wave elastography for thyroid nodules
Shear wave elastography: A new ultrasound imaging mode for the differential diagnosis of benign and malignant thyroid nodules. J Clin Endocrinol Metab 2010; 95:5281-8
(PDF File for saving and printing, 92 KB)
THYROID AND PREGNANCY Universal screening for thyroid disorders during pregnancy
Wang W et al The prevalence of thyroid disorders during pregnancy in China: the benefits of universal screening in the first trimester of pregnancy. Eur J Endocrinol. November 8, 2010 [Epub ahead of print].
(PDF File for saving and printing, 115 KB)
HYPERTHYROIDISM The natural progression of subclinical hyperthyroidism
Vadiveloo T et al. The Thyroid Epidemiology, Audit, and Research Study (TEARS): the natural history of endogenous subclinical hyperthyroidism. J Clin Endocrinol Metab. October 6, 2010 [Epub ahead of print].
(PDF File for saving and printing, 94 KB)
HYPERTHYROIDISM T3-predominant Graves’ disease
Ito M et al. Type 1 and type 2 iodothyronine deiodinases in the thyroid gland of patients with 3,5,3′-triiodothyronine-predominant Graves’ disease. Eur J Endocrinol. October 11, 2010 [Epub ahead of print].
(PDF File for saving and printing, 97 KB)
HIGHLIGHT: Graves’ Disease Foundation The Graves’ Disease Foundation holds successful annual Patient & Family Conference
ATA ALLIANCE FOR THYROID PATIENT EDUCATION